- Ph.D., Bioengineering, Temple University, 2016
- B.S., Engineering Science, Hofstra University, 2008
- Professional Engineer Mechanical, Delaware, #23247
- ISO 10993-1:2018 - Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
- Adjunct Professor, Temple University College of Engineering (2022)
- Michael Brown Penn-GSK Postdoctoral Research Fellowship
- Hartwell Foundation Postdoctoral Research Fellowship
- Lung Repair and Regeneration Consortium (LRRC) Travel Award
- National Aeronautics and Space Administration (NASA) Graduate Student Research Program (GSRP) fellowship
- Temple University College of Engineering Poster Competition 1st place award
- ASTM, Member
- AAMI, Member
- ASME, Member; Chair of Bioprinting Hardware Standard committee (2021-2022)
- Biomedical Engineering Society, Member
- Tissue Engineering and Regenerative Medicine International Society, Member
- Theta Tau, Member
Dr. Stabler has extensive expertise in biotechnology evaluation, from product conceptualization through regulatory strategy. His experience centers around the intersection of mechanical performance and biocompatibility.
Being classically trained as a bioengineer, Dr. Stabler's research deals with the interaction of biomaterials and the body. He is certified to evaluate and perform risk assessments relating to the biocompatibility of medical devices in accordance with ISO 10993. As a licensed mechanical engineer, Dr. Stabler evaluates the performance of consumer products and medical devices through preclinical testing protocols and technology assessment, and has extensive experience interacting with and evaluating quality systems, design controls, risk management, post market surveillance, and failure analysis.
Dr. Stabler's expertise includes medical device and drug delivery platform development for implantable cardiovascular devices, pulmonary therapies, medical device biologic safety, biocompatibility, and tissue engineered medical products. His experience includes design evaluation and mechanical behavior of nitinol-based cardiovascular implants (e.g., occluders, prosthetic heart valves), functional evaluation of balloon catheters and expandable stents, 3D-printing for biomedical purposes (e.g., bioprinting), tissue engineering and regenerative medicine, bioreactor design, in vivo disease modeling, and ex vivo microphysiologic assay development (e.g., organoids, microfluidic devices). Dr. Stabler is proficient in mechanical testing of medical devices and biomaterials, histological analyses, cell and molecular biology techniques, and has extensive experience working with animal models for disease and regeneration studies, as well as a multitude of microscopy and dry lab techniques. As a data scientist, he has experience in handling large datasets, market and strategic analysis, and data visualization tools.
Dr. Stabler holds NAMSA ISO 10993 Series 1 certification for biocompatibility evaluation and risk assessment of medical devices. His research has included the development of methods for manufacturing bioengineered lungs, bioreactor design for stem cell culture, disease modeling of acute respiratory distress syndrome and pulmonary fibrosis, and tissue engineering of lung, tracheal, and bone tissues. Dr. Stabler has published a number of papers in the field of tissue engineering and regenerative medicine, and his research contributed to the founding of a medical device startup company.